Mepivacaine: Clinical Trials

67 trials of Mepivacaine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 11 unknown, 4 terminated, 3 enrolling by invitation. 27 Phase 4, 22 Not applicable, 8 Phase 3, 6 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 427Completed 17, Unknown 5, Enrolling by invitation 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Not applicable22Completed 12, Unknown 5, Not yet recruiting 2, Enrolling by invitation 1, Terminated 1, Withdrawn 1
Phase 38Completed 5, Active not recruiting 1, Terminated 1, Unknown 1
Phase 26Completed 5, Terminated 1
Phase 15Completed 5

Follow Mepivacaine: new trials by email Literature Review of Mepivacaine trials Research Report on Mepivacaine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immersive VR to Reduce Stress, Anxiety, and Pain During PICC/Midline Placement
Immersive Virtual Reality, Peripherally Inserted Central Catheter (PICC), Mepivacaine 2% Injection - Vasoconstriction, Biomarkers
Not applicableNot yet recruitingdiana garcia2022027-01-152026-07-10
Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total Knee Arthroplasty
Mepivacaine Injection, Chloroprocaine Injection - Recovery Period, Anesthesia
Phase 4Not yet recruitingNova Scotia Health Authority1702026-03-312026-02-06
Hysteroscopy Anesthesia for Relief of Pain
Local paracervical Anesthesia, Placebo - Pain Management, Outpatient Hysteroscopy
Not applicableNot yet recruitingMaimónides Biomedical Research Institute of Córdoba702025-09-062025-09-17
Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome
Dry Needling, Lidocaine Hydrochloride, Mepivacaine Hydrochloride - Myofascial Pain Syndrome, Temporomandibular Joint Disorders
Not applicableCompletedSümer Münevveroğlu752025-05-012025-08-08
Assessment of Anesthetic Efficacy and Hemodynamic Stability of Two LA Drugs for Hypertensive Patients
4% Articaine HCL With 1:100,000 Epinephrine, 3% plain mepivacaine HCL - Hypertension
Not applicableEnrolling by invitationTanta University602025-01-102025-11-18
Local Anesthetic Clinical Trial
Lidocaine, Bupivacaine Hydrochloride, Mepivacaine Hydrochloride - Mohs Micrographic Surgery, Anesthesia, Local
Phase 4Enrolling by invitationBaylor Research Institute4002025-01-072026-05-22
Avoid With Locoregional Analgesia Persistant Postoperative Pain In Children
Carbocaine, Profofol and/or Suxaméthonium and/or Sévoflurane - Persistent Postoperative Pain
Phase 3UnknownNantes University Hospital2082024-06-062024-06-12
Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks
Mepivacaine, Bupivacaine - Ankle Block, Foot Surgery
Phase 4Enrolling by invitationMayo Clinic502024-03-112026-09-18
Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA
Mepivacaine, Bupivacaine - Anesthesia, Spinal, Arthroplasty, Replacement, Knee
Phase 4CompletedPrisma Health-Upstate1382024-02-162025-08-28
Hemodynamic Effects of Different Vasoconstrictors in Mandibular Exodontia
2% Mepivacaine with 1:100,000 epinephrine, 2% Mepivacaine with 1:55,000 Epinephrine Bitartrate - Hemodynamics, Pain
Phase 4CompletedKing Abdulaziz University522024-02-102025-06-12
Wide Awake Open Carpal Tunnel Release With or Without a Tourniquet
Mepivacaine, Combinations - Carpal Tunnel Syndrome
Not applicableUnknownRegion Skane1202024-01-092023-12-26
Combination of Buffered Anesthetic to Treat Mandibular Molars
Sodium bicarbonate, Lidocaine w/ epi, Articaine w/ epi - Symptomatic Irreversible Pulpitis
Phase 4TerminatedIndiana University402023-12-052025-05-13
Stellate Ganglion Block for COVID-induced Parosmia
Stellate Ganglion Block, Placebo Sham Injection - COVID-19-Induced Parosmia
Phase 2CompletedWashington University School of Medicine482023-10-252025-11-10
Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers
Mepivacaine - Regional Anesthesia Morbidity, Pain, Acute
Phase 1CompletedBrigham and Women's Hospital402023-09-282025-11-05
Articaine Efficacy and Safety for 3 Years Old Children
Mepivacaine 2% with epinephrine 1:100,000, Articaine (4%) with epinephrine 1:100,000 - Dental Caries in Children, Dental Diseases
Phase 3Active not recruitingQassim Health Cluster2002023-07-012024-12-27
Impact of Tramadol Addiction On Dental Anesthesia Success
articaine@ (4% 1:100000 epinephrine) dental anesthesia - Dental Pain and Sensation Disorder, Anesthesia, Local
Phase 4UnknownUniversity of Algiers3002023-06-102023-06-18
Spinal Hypobaric Local Anesthetic Study
Spinal hypobaric Mepivacaine Local Anesthetic Injection, Spinal hypobaric Bupivacaine Local Anesthetic Injection - Anesthesia, Local
CompletedUniversity Health Network, Toronto602023-06-092025-03-28
Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty
Bupivacaine Injection, Dexamethasone injection, Fentanyl - Total Knee Replacement, Genicular Nerve Block
Phase 4CompletedHospital for Special Surgery, New York2442023-06-072025-10-08
Healing Process and Blood Sugar Level Following Local Anesthetic Infiltration With and Without Vasoconstrictor
Local anaesthesia with vasocontrictor (Mepivacaine hydrochloride 20 mg (2%) + Levonordefrin hydrochloride 0.06 mg) - Diabetes, Anesthesia, Local
Not applicableCompletedMinia University402023-05-202024-12-31
Photobiomodulation for Controlling Pre-Local Anesthetic Injection Pain
Photobiomodulation, Mepivacaine hydrochloride in combination with epinephrine, Photobiomodulation simulation - Fear Needles
Not applicableCompletedUniversity of Nove de Julho502023-02-152024-07-18

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Pain (9)  ·  Agnosia (4)  ·  Pain, Postoperative (3)  ·  Anosmia (2)  ·  Bites and Stings (2)  ·  COVID-19 (2)  ·  Dental Pulp Diseases (2)  ·  Olfaction Disorders (2)  ·  Osteoarthritis, Hip (2)  ·  Osteoarthritis, Knee (2)  ·  Sensation Disorders (2)  ·  Acute Kidney Injury (1)  ·  Acute Pain (1)  ·  Anterior Cruciate Ligament Injuries (1)  ·  Anxiety Disorders (1)

Sponsors

Cairo University (6)  ·  Hospital for Special Surgery, New York (5)  ·  Brigham and Women's Hospital (3)  ·  Duke University (2)  ·  Mayo Clinic (2)  ·  University Health Network, Toronto (2)  ·  Vanderbilt University Medical Center (2)  ·  Washington University School of Medicine (2)  ·  ASST Gaetano Pini-CTO (1)  ·  Afshan Amjad Ali (1)  ·  Azienda Sanitaria-Universitaria Integrata di Udine (1)  ·  Baylor Research Institute (1)  ·  Birmingham Women's and Children's NHS Foundation Trust (1)  ·  Centre Hospitalier Annecy Genevois (1)  ·  Centre Hospitalier Universitaire, Amiens (1)

Countries

United States (23)  ·  Egypt (6)  ·  Brazil (4)  ·  France (3)  ·  Italy (3)  ·  Spain (3)  ·  Canada (2)  ·  Saudi Arabia (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Top investigators

Abeer Salem, MD (1)  ·  Ahmed H Wahba (1)  ·  Ahmed Maged, MD (1)  ·  Amanda Kumar, MD, PhD (1)  ·  Amaury Pozos, MSc, PhD (1)  ·  Ana Sanchez, MD, PhD (1)  ·  Anna Carolina Horliana, PhD (1)  ·  Asya A. Almansour, SBPD (1)  ·  Atyaf A. Alhunti (1)  ·  Benjamin Canales, MD (1)  ·  Bridget Pulos, MD (1)  ·  Campana Philippe, MD (1)  ·  Christopher Sobey, MD (1)

Results publications

PMID 10195537, PMID 15041620, PMID 15502049, PMID 15804720, PMID 17052637, PMID 17368248, PMID 17589623, PMID 17656294, PMID 19856040, PMID 20332307, PMID 20340056, PMID 20482446, PMID 20835569, PMID 21196862, PMID 21217614, PMID 21555171, PMID 21809720, PMID 22981094, PMID 25509976, PMID 26535092, PMID 26546298, PMID 27661661, PMID 28538371, PMID 29357330, PMID 29847387, PMID 30831101, PMID 32570188, PMID 33431616, PMID 33537703, PMID 33575000, PMID 34261807, PMID 34308957, PMID 34391560, PMID 34759690, PMID 35611933, PMID 35858717, PMID 37865418, PMID 37888047, PMID 38914976, PMID 39400883, PMID 39653970, PMID 39685488, PMID 40504522, PMID 42324523, PMID 42359695, PMID 7646610, PMID 8891747, PMID 9832183

NIH funding

2025 (1)